BILATERAL BREAST CARCINOMA
Clinical trials for BILATERAL BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BILATERAL BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for BILATERAL BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to outsmart tough breast cancers
Disease control OngoingThis early-stage trial is testing whether adding an experimental drug called berzosertib to standard radiation therapy can better control breast cancer that has not responded well to chemotherapy. The main goal is to find the safest and most effective dose of the drug when given …
Matched conditions: BILATERAL BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug tested to stop breast Cancer's return
Disease control OngoingThis study is for people with a type of breast cancer (HER2-negative) that did not completely disappear after standard chemotherapy before surgery. It tests whether adding a drug called ixabepilone after surgery helps control the cancer better than standard follow-up care alone. …
Matched conditions: BILATERAL BREAST CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC